Structure/NN
and/CC
Expression/NN
Analyses/NNS
of/IN
SVA/NN
Elements/NNS
in/IN
Relation/NN
to/TO
Functional/JJ
Genes/NNS
./.
====================
SINE-VNTR-Alu/NN
(/(
SVA/NN
)/)
elements/NNS
are/VBP
present/JJ
in/IN
hominoid/JJ
primates/NNS
and/CC
are/VBP
divided/VBN
into/IN
6/CD
subfamilies/NNS
(/(
SVA-A/NN
to/TO
SVA-F/NN
)/)
and/CC
active/JJ
in/IN
the/DT
human/JJ
population/NN
./.
====================
Using/VBG
a/DT
bioinformatic/JJ
tool/NN
,/,
22/CD
SVA/NN
element-associated/JJ
genes/NNS
are/VBP
identified/VBN
in/IN
the/DT
human/JJ
genome/NN
./.
====================
In/IN
an/DT
analysis/NN
of/IN
genomic/JJ
structure/NN
,/,
SVA/NNP
elements/NNS
are/VBP
detected/VBN
in/IN
the/DT
5/CD
'/``
untranslated/JJ
region/NN
(/(
UTR/NN
)/)
of/IN
HGSNAT/JJ
(/(
SVA-B/NN
)/)
,/,
MRGPRX3/NNP
(/(
SVA-D/NN
)/)
,/,
HYAL1/NNP
(/(
SVA-F/NNP
)/)
,/,
TCHH/NNP
(/(
SVA-F/NNP
)/)
,/,
and/CC
ATXN2L/NN
(/(
SVA-F/NNP
)/)
genes/NNS
,/,
while/IN
some/DT
elements/NNS
are/VBP
observed/VBN
in/IN
the/DT
3'UTR/NN
of/IN
SPICE1/NN
(/(
SVA-B/NN
)/)
,/,
TDRKH/NNP
(/(
SVA-C/NN
)/)
,/,
GOSR1/NN
(/(
SVA-D/NN
)/)
,/,
BBS5/NNP
(/(
SVA-D/NN
)/)
,/,
NEK5/NNP
(/(
SVA-D/NN
)/)
,/,
ABHD2/NNP
(/(
SVA-F/NNP
)/)
,/,
C1QTNF7/NNP
(/(
SVA-F/NNP
)/)
,/,
ORC6L/NNP
(/(
SVA-F/NNP
)/)
,/,
TMEM69/NNP
(/(
SVA-F/NNP
)/)
,/,
and/CC
CCDC137/NN
(/(
SVA-F/NNP
)/)
genes/NNS
./.
====================
They/PRP
could/MD
contribute/VB
to/TO
exon/NN
extension/NN
or/CC
supplying/VBG
poly/RB
A/NN
signals/NNS
./.
====================
LEPR/NN
(/(
SVA-C/NN
)/)
,/,
ALOX5/NN
(/(
SVA-D/NN
)/)
,/,
PDS5B/NN
(/(
SVA-D/NN
)/)
,/,
and/CC
ABCA10/NN
(/(
SVA-F/NN
)/)
genes/NNS
also/RB
showed/VBD
alternative/JJ
transcripts/NNS
by/IN
SVA/NN
exonization/NN
events/NNS
./.
====================
Dominant/JJ
expression/NN
of/IN
HYAL1_SVA/NN
appeared/VBD
in/IN
lung/NN
tissues/NNS
,/,
while/IN
HYAL1_noSVA/NN
showed/VBD
ubiquitous/JJ
expression/NN
in/IN
various/JJ
human/JJ
tissues/NNS
./.
====================
Expression/NN
of/IN
both/DT
transcripts/NNS
(/(
TDRKH_SVA/NN
and/CC
TDRKH_noSVA/NN
)/)
of/IN
the/DT
TDRKH/NN
gene/NN
appeared/VBD
to/TO
be/VB
ubiquitous/JJ
./.
====================
Taken/VBN
together/RB
,/,
these/DT
data/NNS
suggest/VBP
that/IN
SVA/NN
elements/NNS
cause/VBP
transcript/NN
isoforms/NNS
that/WDT
contribute/VBP
to/TO
modulation/NN
of/IN
gene/NN
regulation/NN
in/IN
various/JJ
human/JJ
tissues/NNS
./.
====================
The/DT
human/JJ
genome/NN
contains/VBZ
actively/RB
moving/VBG
retrotransposons/NNS
(/(
human/JJ
endogenous/JJ
retrovirus/NN
[/(
HERV/NN
]/)
,/,
long/JJ
interspersed/JJ
nucleotide/NN
element/NN
[/(
LINE/NN
]/)
,/,
and/CC
short/JJ
interspersed/JJ
nucleotide/NN
element/NN
[/(
SINE/NN
]/)
)/)
./.
====================
Approximately/RB
36/CD
%/NN
of/IN
the/DT
human/JJ
genome/NN
has/VBZ
been/VBN
generated/VBN
through/IN
retrotransposition/NN
of/IN
LINE/NN
and/CC
other/JJ
RNA/NN
species/NNS
by/IN
the/DT
LINE/NN
reverse/JJ
transcriptase/NN
[/(
1/CD
,/,
2/CD
]/)
./.
====================
Retrotransposition/NN
is/VBZ
progressing/VBG
in/IN
the/DT
human/JJ
population/NN
by/IN
L1/NN
,/,
Alu/NNP
,/,
and/CC
SINE-VNTR-Alu/NN
(/(
SVA/NN
)/)
insertions/NNS
[/(
3/CD
]/)
./.
====================
L1/NN
is/VBZ
an/DT
autonomous/JJ
retrotransposon/NN
that/DT
contains/VBZ
an/DT
internal/JJ
RNA/NN
polymerase/NN
II/CD
promoter/NN
and/CC
a/DT
reverse/JJ
transcriptase/NN
,/,
whereas/IN
Alu/NN
and/CC
SVA/NN
lack/NN
activities/NNS
for/IN
independent/JJ
mobilization/NN
[/(
4/CD
,/,
5/CD
]/)
./.
====================
Therefore/RB
,/,
Alu/NNP
and/CC
SVA/NN
are/VBP
assumed/VBN
to/TO
use/VB
the/DT
L1/NN
protein/NN
machinery/NN
for/IN
their/PRP$
own/JJ
mobilization/NN
[/(
3/CD
]/)
,/,
and/CC
retrotransposition/NN
events/NNS
of/IN
marked/JJ
SVA/NN
elements/NNS
occur/VBP
indeed/RB
by/IN
L1/NN
elements/NNS
in/IN
human/JJ
cultured/VBN
cells/NNS
[/(
5/CD
,/,
6/CD
]/)
./.
====================
The/DT
SVA/NN
elements/NNS
were/VBD
originally/RB
named/VBN
from/IN
the/DT
SINE-R/NN
retroposon/NN
,/,
derived/VBN
from/IN
an/DT
endogenous/JJ
retrovirus/NN
,/,
the/DT
HERV-K/NN
LTR/NN
element/NN
./.
====================
SINE-R11/NN
,/,
14/CD
,/,
and/CC
19/CD
have/VBP
been/VBN
isolated/VBN
by/IN
colony/NN
blot/NN
hybridization/NN
using/VBG
the/DT
LTR/NN
element/NN
as/IN
probe/NN
[/(
7/CD
]/)
./.
====================
SINE-R.C2/NN
has/VBZ
been/VBN
found/VBN
in/IN
the/DT
third/JJ
intron/NN
of/IN
the/DT
C2/NN
gene/NN
on/IN
the/DT
short/JJ
arm/NN
of/IN
human/JJ
chromosome/NN
6/CD
,/,
which/WDT
was/VBD
a/DT
human-specific/JJ
element/NN
[/(
8/CD
]/)
./.
====================
Within/IN
the/DT
Xq21.3/NN
block/VBP
,/,
two/CD
SINE-R/NN
retroposons/NNS
(/(
HS307/NN
and/CC
HS408/NN
)/)
were/VBD
identified/VBN
[/(
9/CD
]/)
./.
====================
Multiple/JJ
copy/NN
numbers/NNS
of/IN
retroposons/NNS
have/VBP
been/VBN
successively/RB
detected/VBN
in/IN
hominoid/JJ
primates/NNS
and/CC
humans/NNS
[/(
9-16/CD
]/)
./.
====================
Other/JJ
similar/JJ
sequences/NNS
have/VBP
been/VBN
associated/VBN
with/IN
Alu-like/JJ
sequences/NNS
within/IN
the/DT
HLA-RP1/NN
(/(
STK19/NN
)/)
gene/NN
[/(
17/CD
]/)
./.
====================
These/DT
composite/JJ
retroposons/NNS
with/IN
the/DT
entire/JJ
structure/NN
are/VBP
named/VBN
SVA/NN
(/(
SINE-R/NN
,/,
VNTR/NN
,/,
and/CC
Alu/FW
)/)
./.
====================
The/DT
SVA/NN
families/NNS
are/VBP
evolutionarily/RB
young/JJ
and/CC
hominoid-specific/JJ
retroelements/NNS
./.
====================
They/PRP
have/VBP
ability/NN
to/TO
influence/VB
a/DT
genomic/JJ
locus/NN
in/IN
which/WDT
they/PRP
reside/VBP
and/CC
cause/VBP
various/JJ
human/JJ
diseases/NNS
as/IN
insertional/JJ
mutagens/NNS
./.
====================
In/IN
fact/NN
,/,
Fukuyama/NNP
muscular/JJ
dystrophy/NN
(/(
FCMD/NN
)/)
is/VBZ
derived/VBN
from/IN
the/DT
polymorphic/JJ
SVA-E/NN
insertion/NN
in/IN
the/DT
3/CD
'/``
untranslated/JJ
region/NN
(/(
UTR/NN
)/)
of/IN
the/DT
FUKUTIN/NN
gene/NN
[/(
18/CD
]/)
./.
====================
SVA/NN
elements/NNS
could/MD
also/RB
drive/VBP
transcription/NN
of/IN
functional/JJ
genes/NNS
./.
====================
In/IN
the/DT
5/CD
'/``
upstream/RB
region/NN
of/IN
TBPL2/NN
,/,
the/DT
SVA/NN
element/NN
serves/VBZ
as/IN
a/DT
promoter/NN
,/,
while/IN
the/DT
SVA-D/NN
element/NN
in/IN
the/DT
WDR66/NN
gene/NN
promotes/VBZ
the/DT
transcription/NN
of/IN
a/DT
human-specific/JJ
transcript/NN
variant/JJ
[/(
19/CD
]/)
./.
====================
Here/RB
,/,
we/PRP
analyzed/VBD
structure/NN
variants/NNS
of/IN
functional/JJ
genes/NNS
mediated/VBN
by/IN
SVA/NN
subfamilies/NNS
and/CC
examined/VBN
their/PRP$
expression/NN
patterns/NNS
in/IN
various/JJ
human/JJ
tissues/NNS
./.
====================
Bioinformatic/JJ
analysis/NN
====================
To/TO
identify/VB
SVA/NN
consensus/NN
sequences/NNS
in/IN
the/DT
human/JJ
genome/NN
,/,
we/PRP
obtained/VBD
SVA/NN
sequences/NNS
from/IN
the/DT
Giri/NN
database/NN
(/(
http/NN
:/:
//www.girinst.org/JJ
)/)
./.
====================
The/DT
SVA/NN
subfamilies/NNS
were/VBD
aligned/VBN
using/VBG
the/DT
BioEdit/NN
program/NN
[/(
20/CD
]/)
./.
====================
Then/RB
,/,
we/PRP
identified/VBD
SVAs/NNS
in/IN
each/DT
region/NN
./.
====================
RepeatMasker/NN
(/(
http/NN
:/:
//www.repeatmasker.org/JJ
)/)
and/CC
the/DT
UCSC/NN
genome/NN
site/NN
(/(
http/NN
:/:
//genome.ucsc.edu/FW
)/)
were/VBD
employed/VBN
to/TO
analyze/VB
isoform/NN
structures/NNS
of/IN
functional/JJ
genes/NNS
./.
====================
The/DT
human/JJ
expressed/VBN
sequence/NN
tag/NN
and/CC
RefSeq/NN
mRNA/NN
were/VBD
also/RB
used/VBN
to/TO
identify/VB
alternatively/RB
spliced/VBN
transcripts/NNS
./.
====================
The/DT
expression/NN
pattern/NN
of/IN
SVA/NN
fusion/NN
genes/NNS
in/IN
normal/JJ
human/JJ
tissues/NNS
was/VBD
analyzed/VBN
using/VBG
GeneCard/JJ
(/(
http/NN
:/:
//www.genecards.org/JJ
)/)
./.
====================
We/PRP
obtained/VBD
microarray/NN
data/NNS
from/IN
the/DT
BioGPS/NN
database/NN
,/,
and/CC
then/RB
we/PRP
generated/VBD
a/DT
heatmap/JJ
according/VBG
to/TO
microarray/NN
values/NNS
./.
====================
High/JJ
expression/NN
levels/NNS
were/VBD
indicated/VBN
by/IN
brighter/JJ
color/JJ
,/,
and/CC
low/JJ
expression/NN
levels/NNS
were/VBD
indicated/VBN
by/IN
darker/NN
color/JJ
./.
====================
Human/JJ
RNA/NN
samples/NNS
====================
A/DT
human/JJ
20-RNA/JJ
tissue/NN
master/JJ
panel/NN
(/(
1/LS
,/,
adrenal/JJ
gland/CC
;/:
2/LS
,/,
bone/NN
marrow/NN
;/:
3/LS
,/,
cerebellum/JJ
;/:
4/CD
,/,
whole/JJ
brain/NN
;/:
5/CD
,/,
fetal/JJ
brain/NN
;/:
6/CD
,/,
fetal/JJ
liver/NN
;/:
7/CD
,/,
heart/RB
;/:
8/CD
,/,
kidney/NNP
;/:
9/CD
,/,
liver/RB
;/:
10/CD
,/,
lung/NN
;/:
11/CD
,/,
placenta/NN
;/:
12/CD
,/,
prostate/VBP
;/:
13/CD
,/,
salivary/JJ
gland/CC
;/:
14/CD
,/,
skeletal/JJ
muscle/NN
;/:
15/CD
,/,
spinal/JJ
cord/NN
;/:
16/CD
,/,
testis/NN
;/:
17/CD
,/,
thymus/DT
;/:
18/CD
,/,
thyroid/NN
;/:
19/CD
,/,
trachea/RB
;/:
20/CD
,/,
uterus/RB
)/)
was/VBD
purchased/VBN
from/IN
Clontech/DT
(/(
Mountain/NNP
View/NNP
,/,
CA/NNP
,/,
USA/NNP
)/)
./.
====================
Reverse-transcription/NN
(/(
RT/NN
)/)
and/CC
reverse/JJ
transcription/NN
polymerase/NN
chain/NN
reaction/NN
(/(
RT-PCR/NN
)/)
amplification/NN
====================
To/TO
eliminate/VB
possible/JJ
DNA/NN
contamination/NN
of/IN
purchased/VBN
RNA/NN
samples/NNS
,/,
Turbo/NN
DNA-free/JJ
(/(
Ambion/NN
,/,
Austin/NN
,/,
TX/NN
,/,
USA/NN
)/)
was/VBD
used/VBN
according/VBG
to/TO
the/DT
manufacturer/NN
's/POS
instructions/NNS
./.
====================
A/DT
no-RT/NN
control/NN
was/VBD
also/RB
amplified/VBD
to/TO
double-check/VB
the/DT
absence/NN
of/IN
DNA/NN
contamination/NN
./.
====================
Quantity/NN
of/IN
RNA/NN
samples/NNS
was/VBD
measured/VBN
using/VBG
a/DT
ND-1000/CD
UV-Vis/NN
spectrophotometer/NN
(/(
NanoDrop/NN
,/,
Wilmington/JJ
,/,
DE/NN
,/,
USA/NN
)/)
./.
====================
Moloney-Murine-Leukemia-Virus/NN
reverse/JJ
transcriptase/NN
with/IN
an/DT
annealing/JJ
temperature/NN
of/IN
42â„ƒ/CD
was/VBD
used/VBN
for/IN
the/DT
RT/NN
reaction/NN
with/IN
RNase/NN
inhibitor/NN
(/(
Promega/NN
,/,
Madison/NN
,/,
WI/NN
,/,
USA/NN
)/)
./.
====================
To/TO
develop/VB
the/DT
specific/JJ
primers/NNS
for/IN
individual/JJ
alternative/JJ
transcripts/NNS
,/,
primer/NN
pairs/NNS
were/VBD
designed/VBN
with/IN
the/DT
aid/NN
of/IN
Primer3/NN
(/(
http/NN
:/:
//frodo.wi.mit.edu//JJ
)/)
(/(
Table/JJ
1/CD
)/)
./.
====================
In/IN
each/DT
run/NN
,/,
1/CD
ÂµL/NN
of/IN
cDNA/NN
was/VBD
used/VBN
as/IN
template/JJ
for/IN
amplification/NN
per/FW
reaction/NN
./.
====================
RT-PCR/NN
was/VBD
performed/VBN
using/VBG
reactions/NNS
containing/VBG
a/DT
mixed/JJ
cDNA/NN
template/NN
,/,
representing/VBG
a/DT
combination/NN
of/IN
different/JJ
tissues/NNS
examined/VBN
./.
====================
RT-PCR/NN
amplification/NN
for/IN
functional/JJ
genes/NNS
and/CC
a/DT
housekeeping/JJ
gene/NN
was/VBD
carried/VBN
out/RP
for/IN
30/CD
cycles/NNS
of/IN
94â„ƒ/CD
for/IN
3/CD
minutes/NNS
,/,
56-60â„ƒ/CD
for/IN
1/CD
minute/JJ
,/,
and/CC
72â„ƒ/CD
for/IN
3/CD
minutes/NNS
./.
====================
As/IN
a/DT
standard/JJ
control/NN
,/,
G3PDH/NN
was/VBD
amplified/VBN
through/IN
RT-PCR/NN
in/IN
human/JJ
tissues/NNS
./.
====================
PCR/NN
products/NNS
were/VBD
loaded/VBN
on/IN
1-2/CD
%/NN
agarose/NN
gels/NNS
and/CC
stained/VBD
with/IN
ethidium/NN
bromide/NN
./.
====================
SVAs/NNS
are/VBP
composite/JJ
elements/NNS
consisting/VBG
of/IN
multiple/JJ
domains/NNS
:/:
a/DT
CCCTCT/NN
repeat/NN
,/,
Alu-like/JJ
domain/NN
,/,
a/DT
GC-rich/JJ
variable/JJ
number/NN
of/IN
tandem/JJ
repeat/NN
(/(
VNTR/NN
)/)
,/,
and/CC
SINE-R/NN
derived/VBN
from/IN
the/DT
HERV-K/NN
LTR/NN
element/NN
[/(
7-9/CD
,/,
21/CD
,/,
22/CD
]/)
./.
====================
They/PRP
are/VBP
flanked/VBN
by/IN
target/NN
site/NN
duplications/NNS
and/CC
terminate/VB
in/IN
a/DT
poly/RB
(/(
A/NN
)/)
tail/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
In/IN
genomic/JJ
sequence/NN
analysis/NN
,/,
SVA/NN
elements/NNS
are/VBP
present/JJ
in/IN
G/NN
+/JJ
C-rich/JJ
regions/NNS
;/:
however/RB
,/,
they/PRP
do/VBP
not/RB
have/VB
any/DT
preferences/VBZ
for/IN
inter-/NN
or/CC
intragenic/JJ
regions/NNS
./.
====================
SVA/NN
families/NNS
are/VBP
separated/VBN
into/IN
six/CD
subfamilies/NNS
(/(
SVA-A/NN
to/TO
SVA-F/NN
)/)
,/,
based/VBN
upon/IN
point/NN
mutation/NN
and/CC
insertion/NN
and/CC
deletion/NN
events/NNS
within/IN
the/DT
SINE-R/NN
[/(
22/CD
]/)
./.
====================
Among/IN
them/PRP
,/,
four/CD
subfamilies/NNS
(/(
SVA-A/NN
,/,
SVA-B/NN
,/,
SVA-C/NN
,/,
SVA-D/NN
)/)
are/VBP
present/JJ
in/IN
gibbons/NNS
and/CC
orangutans/NNS
,/,
while/IN
two/CD
subfamilies/NNS
(/(
SVA-E/NN
and/CC
SVA-F/NN
)/)
are/VBP
restricted/JJ
to/TO
the/DT
human/JJ
lineage/NN
[/(
22/CD
]/)
./.
====================
SVA/NN
elements/NNS
residing/VBG
in/IN
genes/NNS
are/VBP
potentially/RB
disruptive/JJ
in/IN
either/CC
orientation/NN
./.
====================
Approximately/RB
1/3/CD
of/IN
all/DT
SVA/NN
elements/NNS
in/IN
the/DT
human/JJ
genome/NN
reside/NN
in/IN
genic/JJ
regions/NNS
,/,
with/IN
20/CD
%/NN
of/IN
those/DT
SVA/NN
elements/NNS
being/VBG
in/IN
the/DT
same/JJ
orientation/NN
as/IN
a/DT
gene/NN
[/(
23/CD
]/)
./.
====================
As/IN
shown/VBN
in/IN
Fig/NN
./.
====================
2/CD
,/,
we/PRP
analyzed/VBD
the/DT
genomic/JJ
structure/NN
of/IN
SVA/NN
fusion/NN
genes/NNS
using/VBG
bioinformatic/JJ
tools/NNS
(/(
Repeat-Masker/NN
program/NN
and/CC
University/NN
of/IN
California/NN
,/,
Santa/NN
Cruz/NN
[/(
UCSC/NN
]/)
genome/NN
browser/JJR
)/)
./.
====================
SVA/DT
elements/NNS
are/VBP
detected/VBN
in/IN
the/DT
5'UTR/NN
of/IN
the/DT
HGSNAT/JJ
(/(
SVA-B/NN
,/,
AK_057293/NNP
)/)
,/,
MRGPRX3/NNP
(/(
SVA-D/NNP
,/,
NM_054031.2/CD
)/)
,/,
HYAL1/NNP
(/(
SVA-F/NNP
,/,
NM_153281/NNP
)/)
,/,
TCHH/NNP
(/(
SVA-F/NNP
,/,
AK_307946/RB
)/)
,/,
and/CC
ATXN2L/FW
(/(
SVA-F/NNP
,/,
AY_188334-8/NNP
)/)
genes/NNS
,/,
while/IN
some/DT
elements/NNS
are/VBP
observed/VBN
in/IN
the/DT
3'UTR/NN
of/IN
the/DT
SPICE1/NN
(/(
SVA-B/NN
,/,
NM_144718/NNP
)/)
,/,
TDRKH/NNP
(/(
SVA-C/NN
,/,
AK_225160/RB
)/)
,/,
GOSR1/NNP
(/(
SVA-D/NNP
,/,
NM_001007024/NNP
)/)
,/,
BBS5/NNP
(/(
SVA-D/NNP
,/,
NM_1523842/NNP
)/)
,/,
NEK5/NNP
(/(
SVA-D/NNP
,/,
NM_199289/NNP
;/:
AK_126330/RB
)/)
,/,
ABHD2/NNP
(/(
SVA-F/NNP
,/,
NM_007011/NNP
)/)
,/,
C1QTNF7/NNP
(/(
SVA-F/NNP
,/,
NM_031911.3/NNP
)/)
,/,
ORC6L/NNP
(/(
SVA-F/NNP
,/,
AK_024077.1/NNP
)/)
,/,
TMEM69/NNP
(/(
SVA-F/NNP
,/,
NM_016486.2/NNP
)/)
,/,
and/CC
CCDC137/NN
(/(
SVA-F/NNP
,/,
NM_199287.2/CD
)/)
genes/NNS
./.
====================
Within/IN
the/DT
genic/JJ
region/NN
,/,
SVA/NN
elements/NNS
seem/VBP
to/TO
prefer/VB
the/DT
3'UTR/NN
compared/VBN
to/TO
another/DT
regions/NNS
./.
====================
Recently/RB
,/,
a/DT
novel/JJ
promoter/NN
derived/VBN
from/IN
the/DT
SVA-D/NN
element/NN
was/VBD
identified/VBN
in/IN
the/DT
5'UTR/NN
of/IN
the/DT
TBPL2/NN
gene/NN
(/(
DB089735/NN
)/)
[/(
19/CD
]/)
./.
====================
In/IN
order/NN
to/TO
understand/VB
whether/IN
the/DT
SVA/NN
element/NN
could/MD
act/VB
as/IN
a/DT
transcriptional/JJ
regulator/NN
or/CC
not/RB
,/,
the/DT
functional/JJ
activity/NN
of/IN
the/DT
PARK7/NN
SVA/NN
element/NN
was/VBD
performed/VBN
,/,
suggesting/VBG
that/IN
the/DT
SVA/NN
with/IN
the/DT
SINE-R/NN
region/NN
deleted/VBN
showed/VBD
significant/JJ
activity/NN
to/TO
enhance/VB
reporter/NN
gene/NN
activity/NN
in/IN
SK-N-AS/NN
and/CC
MCF-7/NN
cells/NNS
[/(
24/CD
]/)
./.
====================
Likewise/RB
,/,
we/PRP
have/VBP
also/RB
demonstrated/VBD
the/DT
activity/NN
of/IN
an/DT
alternative/JJ
promoter/NN
by/IN
the/DT
HERV-H/NN
LTR/NN
element/NN
in/IN
the/DT
human/JJ
GSDML/NN
gene/NN
[/(
25/CD
]/)
./.
====================
The/DT
transcripts/NNS
of/IN
the/DT
LTR-derived/JJ
promoter/NN
were/VBD
widely/RB
distributed/VBN
in/IN
various/JJ
tissues/NNS
,/,
whereas/IN
the/DT
transcripts/NNS
of/IN
the/DT
original/JJ
promoter/NN
were/VBD
found/VBN
in/IN
stomach/NN
tissues/NNS
,/,
compared/VBN
to/TO
those/DT
of/IN
various/JJ
human/JJ
tissues/NNS
[/(
25/CD
]/)
./.
====================
A/DT
human-specific/JJ
solitary/JJ
LTR/NN
element/NN
(/(
L47334/NN
)/)
was/VBD
previously/RB
shown/VBN
to/TO
have/VB
enhancer/NN
activity/NN
in/IN
Tera-1/NN
human/JJ
testicular/JJ
carcinoma/NN
cells/NNS
[/(
26/CD
]/)
./.
====================
The/DT
varying/VBG
genetic/JJ
structure/NN
of/IN
the/DT
alternative/JJ
promoter/NN
or/CC
enhancer/NN
results/NNS
in/IN
different/JJ
functional/JJ
effects/NNS
[/(
27/CD
]/)
./.
====================
Those/DT
events/NNS
could/MD
regulate/VB
alternative/JJ
transcript/NN
variants/NNS
,/,
resulting/VBG
in/IN
the/DT
production/NN
of/IN
different/JJ
protein/NN
isoforms/NNS
[/(
28/CD
]/)
./.
====================
In/IN
the/DT
case/NN
of/IN
leptin/NN
receptor/NN
isoform/NN
219.1/CD
,/,
SVA/NN
sequences/NNS
form/VBP
the/DT
C-terminal/JJ
coding/VBG
exon/NN
./.
====================
Using/VBG
the/DT
SVA-specific/JJ
probe/NN
,/,
Southern/NN
blot/NN
analysis/NN
in/IN
hominoids/NNS
and/CC
Old/JJ
World/NN
monkeys/NNS
was/VBD
performed/VBN
,/,
indicating/VBG
that/IN
it/PRP
was/VBD
found/VBN
to/TO
be/VB
a/DT
human-specific/JJ
SVA/NN
element/NN
[/(
29/CD
]/)
./.
====================
Furthermore/RB
,/,
new/JJ
exons/NNS
are/VBP
generated/VBN
from/IN
intronic/JJ
retrotransposons/NNS
or/CC
the/DT
elements/NNS
inserts/VBZ
into/IN
the/DT
exon/NN
,/,
leading/VBG
to/TO
a/DT
new/JJ
transcript/NN
[/(
30/CD
]/)
./.
====================
In/IN
the/DT
present/JJ
study/NN
,/,
the/DT
LEPR/NN
(/(
SVA-C/NN
,/,
NM_001003680/CD
)/)
,/,
ALOX5/NN
(/(
SVA-D/NN
,/,
AB_208946/CD
)/)
,/,
PDS5B/NN
(/(
SVA-D/NN
,/,
AK_128502.2/CD
)/)
,/,
and/CC
ABCA10/NN
(/(
SVA-F/NN
,/,
AL_832004/NN
)/)
genes/NNS
showed/VBD
alternative/JJ
transcripts/NNS
by/IN
the/DT
SVA/NN
exonization/NN
event/NN
./.
====================
To/TO
investigate/VB
the/DT
supply/RB
of/IN
alternative/JJ
splicing/NN
sites/NNS
at/IN
SVA/NN
elements/NNS
,/,
we/PRP
analyzed/VBD
related/JJ
splicing/NN
sites/NNS
using/VBG
human/JJ
genomic/JJ
sequences/NNS
(/(
http/NN
:/:
//genome.ucsc.edu//JJ
)/)
(/(
Fig/NN
./.
====================
3/CD
)/)
./.
====================
In/IN
the/DT
case/NN
of/IN
ABCA10/NN
(/(
AL832004/NN
)/)
genes/NNS
,/,
the/DT
SVA/NN
element/NN
provided/VBD
both/CC
a/DT
splicing/NN
donor/NN
and/CC
acceptor/NN
site/NN
for/IN
the/DT
cassette/JJ
exon/NN
./.
====================
In/IN
the/DT
case/NN
of/IN
the/DT
ALOX5/NN
(/(
AB208946/CD
)/)
and/CC
PDS5B/NN
(/(
AK128502/NN
)/)
genes/NNS
,/,
the/DT
SVA/NN
element/NN
provided/VBD
a/DT
splicing/NN
donor/NN
site/NN
for/IN
alternative/JJ
5/CD
'/``
splicing/NN
./.
====================
Conversely/RB
,/,
the/DT
LEPR/NN
(/(
NM001003680/CD
)/)
gene/NN
was/VBD
provided/VBN
a/DT
splicing/NN
acceptor/NN
site/NN
for/IN
alternative/JJ
3/CD
'/``
splicing/NN
./.
====================
These/DT
phenomena/NNS
conformed/VBD
to/TO
the/DT
canonical/JJ
splicing/NN
site/NN
./.
====================
Also/RB
,/,
the/DT
PDS5B/NN
(/(
AK128502/NN
)/)
and/CC
ABCA10/NN
(/(
AL832004/NN
)/)
genes/NNS
induced/VBN
exonization/NN
by/IN
providing/VBG
alternative/JJ
splicing/NN
sites/NNS
in/IN
the/DT
VNTR/NN
region/NN
of/IN
SVA/NN
elements/NNS
./.
====================
Exonization/NN
of/IN
the/DT
LEPR/NN
(/(
NM001003680/CD
)/)
and/CC
ALOX5/NN
(/(
AB208946/CD
)/)
genes/NNS
occurred/VBD
by/IN
the/DT
SINE-R/NN
region/NN
of/IN
SVA/NN
elements/NNS
./.
====================
This/DT
integration/NN
event/NN
of/IN
SVA/NN
elements/NNS
into/IN
the/DT
exon/NN
or/CC
intron/NN
causes/VBZ
the/DT
promotion/NN
of/IN
transcriptional/JJ
variants/NNS
of/IN
functional/JJ
genes/NNS
./.
====================
In/IN
WDR66/NN
(/(
NM_144668/NN
)/)
,/,
the/DT
SVA-F/NN
element/NN
,/,
inserted/VBN
in/IN
intron/NN
19/CD
,/,
could/MD
produce/VB
human-specific/JJ
transcripts/NNS
that/WDT
spliced/VBN
to/TO
the/DT
last/JJ
three/CD
exons/NNS
[/(
19/CD
]/)
./.
====================
Those/DT
transcripts/NNS
,/,
derived/VBN
from/IN
SVA/NN
elements/NNS
,/,
could/MD
have/VB
important/JJ
biological/JJ
function/NN
in/IN
humans/NNS
,/,
therefore/RB
deserving/VBG
further/RBR
investigation/NN
in/IN
various/JJ
tissues/NNS
of/IN
hominoid/JJ
primates/NNS
./.
====================
SVA/NN
elements/NNS
are/VBP
capable/JJ
of/IN
generating/VBG
individual/JJ
variation/NN
in/IN
gene/NN
expression/NN
at/IN
loci/NNS
in/IN
which/WDT
they/PRP
are/VBP
present/JJ
./.
====================
RT-PCR/NN
amplification/NN
could/MD
be/VB
a/DT
good/JJ
indicator/NN
to/TO
detect/VB
alternative/JJ
variants/NNS
derived/VBN
from/IN
SVA/NN
elements/NNS
./.
====================
As/IN
shown/VBN
in/IN
Fig/NN
./.
====================
4/CD
,/,
dominant/JJ
expression/NN
of/IN
HYAL1_SVA/NN
appeared/VBD
in/IN
lung/NN
tissues/NNS
,/,
while/IN
HYAL1_noSVA/NN
showed/VBD
ubiquitous/JJ
expression/NN
in/IN
various/JJ
human/JJ
tissues/NNS
./.
====================
Expression/NN
of/IN
both/DT
transcripts/NNS
(/(
TDRKH_SVA/NN
and/CC
TDRKH_noSVA/NN
)/)
of/IN
the/DT
TDRKH/NN
gene/NN
appeared/VBD
to/TO
be/VB
ubiquitous/JJ
./.
====================
We/PRP
also/RB
examined/VBN
in/IN
silico/NN
expression/NN
of/IN
SVA/NN
fusion/NN
genes/NNS
using/VBG
microarray/NN
data/NNS
obtained/VBN
by/IN
the/DT
BioGPS/NN
database/NN
./.
====================
Transcripts/NNS
of/IN
the/DT
TCHH/NN
and/CC
HYAL1/NN
genes/NNS
appeared/VBD
dominant/JJ
in/IN
placenta/NN
and/CC
liver/NN
,/,
respectively/RB
./.
====================
The/DT
ALOX5/NN
gene/NN
showed/VBD
dominant/JJ
expression/NN
in/IN
whole/JJ
blood/NN
and/CC
lung/NN
./.
====================
Also/RB
,/,
dominant/JJ
expression/NN
of/IN
the/DT
ABHD2/NN
gene/NN
appeared/VBD
in/IN
testis/NN
and/CC
prostate/NN
tissues/NNS
,/,
whereas/IN
the/DT
BBS5/NN
,/,
NEK5/NN
,/,
MRGPRX3/NN
,/,
PDS5B/NN
,/,
OR6W1P/NN
,/,
ABCA10/NN
,/,
TMEM69/CD
,/,
C1QTNF7/NN
,/,
and/CC
ATXN2L/NN
genes/NNS
indicated/VBD
ubiquitous/JJ
expression/NN
(/(
Fig/NN
./.
====================
5/CD
)/)
./.
====================
SVA/NN
elements/NNS
are/VBP
nonautonomous/JJ
retrotransposons/NNS
that/DT
cause/VBP
diseases/NNS
in/IN
humans/NNS
,/,
and/CC
they/PRP
are/VBP
mobilized/VBN
in/IN
trans/JJ
by/IN
active/JJ
L1/NN
elements/NNS
./.
====================
The/DT
quantitative/JJ
real-time/NN
polymerase/NN
chain/NN
reaction/NN
analysis/NN
of/IN
fukutin/JJ
mRNA/NN
in/IN
lymphoblasts/NNS
from/IN
FCMD/NN
patients/NNS
indicated/VBD
that/IN
the/DT
disease/NN
results/NNS
from/IN
SVA-E/NN
insertion/NN
in/IN
the/DT
3'UTR/NN
of/IN
the/DT
FUKUTIN/NN
gene/NN
./.
====================
Sequence/NN
data/NNS
demonstrated/VBD
an/DT
abnormal/JJ
splicing/NN
event/NN
by/IN
the/DT
integration/NN
of/IN
an/DT
SVA-E/NN
element/NN
[/(
18/CD
]/)
./.
====================
In/IN
the/DT
case/NN
of/IN
the/DT
PMS2/NN
gene/NN
,/,
SVA-F/NN
has/VBZ
inserted/VBN
in/IN
intron/NN
7/CD
,/,
and/CC
causes/VBZ
Lynch/NN
syndrome/NN
./.
====================
Sequence/NN
analysis/NN
of/IN
the/DT
RT-PCR/NN
product/NN
revealed/VBD
a/DT
71-bp/JJ
SVA-F/NN
element/NN
between/IN
PMS2/NN
exon/NN
7/CD
and/CC
8/CD
in/IN
the/DT
aberrant/JJ
transcripts/NNS
[/(
31/CD
]/)
./.
====================
Exon/NN
3/CD
of/IN
the/DT
PNPLA2/NN
gene/NN
was/VBD
interrupted/VBN
by/IN
a/DT
1.8-kb/JJ
SVA-F/NN
insertion/NN
,/,
which/WDT
causes/VBZ
lipid/NN
storage/NN
disease/NN
with/IN
subclinical/JJ
myopathy/JJ
[/(
32/CD
]/)
,/,
while/IN
an/DT
SVA-F/NN
element/NN
inserted/VBN
in/IN
intron/NN
1/CD
of/IN
the/DT
ARH/NN
gene/NN
causes/VBZ
hypercholesterolemia/NN
[/(
33/CD
]/)
./.
====================
Taken/VBN
together/RB
,/,
alternative/JJ
promoter/NN
,/,
enhancer/NN
,/,
polyadenylation/NN
,/,
and/CC
exonization/NN
events/NNS
by/IN
SVA/NN
elements/NNS
cause/VBP
various/JJ
transcript/NN
isoforms/NNS
and/CC
evolutionary/JJ
dynamics/NNS
that/IN
contribute/VBP
to/TO
flexibility/NN
in/IN
the/DT
regulation/NN
of/IN
gene/NN
expression/NN
and/CC
hominoid/JJ
radiation/NN
,/,
including/VBG
human/JJ
disease/NN
./.
====================
Nucleotide/JJ
sequence/NN
alignments/NNS
of/IN
SINE-VNTR-Alu/NN
(/(
SVA/NN
)/)
families/NNS
./.
====================
Dots/NNS
indicate/VBP
no/DT
change/NN
to/TO
the/DT
SVA-A/NN
sequences/NNS
,/,
and/CC
dashes/NNS
indicate/VBP
gaps/IN
./.
====================
The/DT
consensus/NN
sequences/NNS
of/IN
SVA-A/NN
,/,
-B/NN
,/,
-C/NN
,/,
-D/NN
,/,
-E/NN
,/,
and/CC
-F/NN
were/VBD
taken/VBN
from/IN
Giri/NN
DB/NN
(/(
http/NN
:/:
//www.girinst.org/JJ
)/)
./.
====================
Main/NN
domains/NNS
(/(
Alu/NNP
,/,
VNTR/NN
,/,
and/CC
SINE-R/NN
)/)
are/VBP
indicated/VBN
./.
====================
Alternative/JJ
splicing/NN
patterns/NNS
of/IN
functional/JJ
genes/NNS
by/IN
SINE-VNTR-Alu/NN
(/(
SVA/NN
)/)
families/NNS
./.
====================
SVA/NN
element/NN
is/VBZ
indicated/VBN
by/IN
the/DT
arrow/NN
./.
====================
Exonization/NN
and/CC
splice/NN
site/NN
analysis/NN
by/IN
SINE-VNTR-Alu/NN
(/(
SVA/NN
)/)
element/NN
in/IN
functional/JJ
genes/NNS
./.
====================
UTR/NN
,/,
untranslated/JJ
region/NN
;/:
ORF/NN
,/,
open/JJ
reading/NN
frame/NN
./.
====================
Reverse/JJ
transcription/NN
polymerase/NN
chain/NN
reaction/NN
analysis/NN
of/IN
transcript/NN
variants/NNS
of/IN
functional/JJ
genes/NNS
in/IN
various/JJ
human/JJ
tissues/NNS
./.
====================
1/LS
,/,
adrenal/JJ
gland/CC
;/:
2/LS
,/,
bone/NN
marrow/NN
;/:
3/LS
,/,
cerebellum/JJ
;/:
4/CD
,/,
whole/JJ
brain/NN
;/:
5/CD
,/,
fetal/JJ
brain/NN
;/:
6/CD
,/,
fetal/JJ
liver/NN
;/:
7/CD
,/,
heart/RB
;/:
8/CD
,/,
kidney/NNP
;/:
9/CD
,/,
liver/RB
;/:
10/CD
,/,
lung/NN
;/:
11/CD
,/,
placenta/NN
;/:
12/CD
,/,
prostate/VBP
;/:
13/CD
,/,
salivary/JJ
gland/CC
;/:
14/CD
,/,
skeletal/JJ
muscle/NN
;/:
15/CD
,/,
spinal/JJ
cord/NN
;/:
16/CD
,/,
testis/NN
;/:
17/CD
,/,
thymus/NN
;/:
18/CD
,/,
thyroid/NN
;/:
19/CD
,/,
trachea/RB
;/:
20/CD
,/,
uterus/NN
./.
====================
G3PDH/NN
indicates/VBZ
the/DT
positive/JJ
control/NN
./.
====================
Heatmap/RB
of/IN
SINE-VNTR-Alu/NN
(/(
SVA/NN
)/)
fusion/NN
gene/NN
expression/NN
profiles/NNS
./.
====================
Horizontal/JJ
lines/NNS
separate/JJ
the/DT
6/CD
clusters/NNS
via/IN
biological/JJ
systems/NNS
./.
====================
SVA/NN
fusion/NN
genes/NNS
are/VBP
ordered/VBN
according/VBG
to/TO
SVA/NN
subfamily/NN
type/NN
at/IN
vertical/JJ
lines/NNS
./.
====================
Values/NNS
increase/VBP
from/IN
dark/NN
to/TO
bright/VB
./.
====================
List/NN
of/IN
RT-PCR/NN
primer/NN
sets/NNS
for/IN
expression/NN
analysis/NN
of/IN
SVA/NN
fusion/NN
genes/NNS
====================
